Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 17, 2024 05:20 ET | Source: IKTOS

Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies

Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies Paris (France), 17 October, 2024 – Iktos, a leader in...
July 08, 2024 03:00 ET | Source: IKTOS

Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery

PRESS RELEASE Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery Synsight provides Iktos with an...
June 18, 2024 03:00 ET | Source: IKTOS

Italfarmaco partners with Iktos on artificial intelligence to speed drug discovery breakthroughs for patients

PRESS RELEASE Italfarmaco partners with Iktos on artificial intelligence to speed drug discovery breakthroughs for patients Combines AI to increase the potential of novel histone deacetylase (HDAC)...
May 02, 2024 02:45 ET | Source: IKTOS

Iktos announces the appointment of Roman Fleck as Chairman of the Board

Paris (France), 2nd May 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the appointment of Roman Fleck as Chairman of the Board. Yann Gaston-Mathé steps...
February 14, 2024 03:00 ET | Source: IKTOS

Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji

Paris (France) and Tokyo (Japan), February 14, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the opening of Iktos K.K., its new subsidiary in Japan....
January 25, 2024 06:30 ET | Source: Centogene NV

CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare...
January 08, 2024 02:00 ET | Source: ULYSSE COMMUNICATION

PR : Iktos and Nerviano Medical Sciences S.r.l Announce Collaboration in Artificial Intelligence for New Drug Discovery

Iktos and Nerviano Medical Sciences S.r.l Announce Collaboration in Artificial Intelligence for New Drug Discovery Paris, France, 8 January, 2023 – Iktos, a company specialized in Artificial...
March 17, 2022 06:30 ET | Source: Centogene NV

CENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer

In November 2019, CENTOGENE first announced the signing of a data access and collaboration agreement to discover and validate novel genetic and biochemical targets for the potential development of new...
November 11, 2021 10:08 ET | Source: LAVA Therapeutics N.V.

LAVA Therapeutics and The Antibody Society Present Emerging Cancer Therapies Virtual Symposium

UTRECHT, The Netherlands and PHILADELPHIA and FRAMINGHAM, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company, today announced that...
November 02, 2021 07:00 ET | Source: Lava Therapeutics N.V.

LAVA Therapeutics Announces Participation at Upcoming Scientific Conferences

UTRECHT, The Netherlands and PHILADELPHIA, Nov. 02, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company focused on developing its proprietary...